However, it has yet to be determined whether targeting Hsp90 with artesunate would influence the stability of AKT and ERK and thereby inhibit the proliferation of Burkitt’s lymphoma cells. This evidence concerns the gene HSP90AA1 and Burkitt lymphoma.